S0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung Cancer

NCT00661193 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

59

Enrollment

NETWORK

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: carboplatin
DRUG: erlotinib hydrochloride
DRUG: paclitaxel

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]